# Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy

> **NCT07496294** · NA · NOT_YET_RECRUITING · sponsor: **Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Menopausal Women
- Menopausal Symptom Relief
- Hormone Therapy
- Menopausal Hormone Therapy

## Interventions

- **DRUG:** Dydrogesterone 10 MG Oral Tablet
- **DRUG:** Micronized progesterone 200 MG
- **DRUG:** Transdermal estradiol

## Key facts

- **NCT ID:** NCT07496294
- **Lead sponsor:** Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07496294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07496294, "Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07496294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*